Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Valeant Pharmaceuticals International Inc T.VRX

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  VRX

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company that develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.
Price: $203.17 Volume: 452,575
Change: $-0.46 % Change: -0.23%
Day High/Low: 205.98/201.09 52 Week High/Low: 204.04/116.01
Last Traded: January 30, 2015 11:00 Transaction Volume: 3
Open: 204.50 Previous Close: 203.63
Bid: 202.62 Ask: 203.49
Bid Size: 500 Ask Size: 800
Market Cap: 67.8b Shares Out: 333.6m
PE Ratio: 125.5 Dividend Yield: N/A


Magna International (T.MG) shareholders bask in glow of rising share price

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   April 22, 2014
0 stars

Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)   April 22, 2014
0 stars

ETF Outlook For Tuesday, April 22, 2014 (PBS, IHE, IYT, EIRL, VRX, AGN, NFLX)   April 22, 2014
0 stars

Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Latest Bullboard Posts

  • RE:RE:RReally?

    0 stars

    HighGrowth wrote: I was about to dump my shares when Valeant said the "could pay a lot more" for it, but the reprieve from overpaying...

    1.5 stars

  • RE:RReally?

    0 stars

    I was about to dump my shares when Valeant said the "could pay a lot more" for it, but the reprieve from overpaying for an acquisition...

    1.5 stars

  • RE:RReally?

    3 stars

    It's up since they made several hundred million on the deal and elected to walk away rather than fight further and gain a pyrrhic victory...

    1.5 stars

  • RReally?

    0 stars

    how this can be up while actavis and allergan are merging. They were not able to eat allergan. the market will remenber. They growth...

    1.5 stars

  • RE:RE:This board is dead.

    0 stars

    call the emoigency

    2 stars